The Fragility Index of Randomized Controlled Trials for Preterm Neonates
BackgroundAs a metric to determine the robustness of trial results, the fragility index (FI) is the number indicating how many patients would be required to reverse the significant results. This study aimed to calculate the FI in randomized controlled trials (RCTs) involving premature.MethodsTrials...
Main Authors: | Huiyi Li, Zhenyu Liang, Qiong Meng, Xin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.876366/full |
Similar Items
-
Frequent fragility of randomized controlled trials for HCC treatment
by: Hao Zhang, et al.
Published: (2021-04-01) -
The statistical fragility of the management options for reverse shoulder arthroplasty: a systematic review of randomized control trial with fragility analysis
by: Tom R. Doyle, MB, BCh, et al.
Published: (2023-08-01) -
Robustness of Significant Dichotomous Outcomes in Randomized Controlled Trials in the Treatment of Patients with COVID-19: A Systematic Analysis
by: Qi Liu, et al.
Published: (2023-01-01) -
Evaluation of statistical significance of randomized controlled trials using diagnostic imaging techniques with fragility index
by: Bahar Taşdelen, et al.
Published: (2019-12-01) -
Timing of Umbilical Cord Clamping in Preterm Neonates: A Randomized Controlled Trial
by: Fatma Zaghloul Mahmoud, et al.
Published: (2024-06-01)